Paper37489366
Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.
Cruz Amaya J and 4 others. Antibodies (Basel), 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization. Papers, record 37489366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37489366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA203348 | NCI NIH HHS | United States | R01CA203348 | PubMed and NIH | NIH RePORTER |
| GM103440 | NIH HHS | United States | P20GM103440 | PubMed and NIH | NIH RePORTER |
| GM110767 | NIH HHS | United States | P30GM110767 | PubMed and NIH | NIH RePORTER |
| RO1CA203348 | NIH HHS | United States | R01CA203348 | PubMed and NIH | NIH RePORTER |
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4966657 | Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. | Immunology | 1968 | https://conductscience.org/library/papers/4966657 | PubMed |
| 2 | 21296976 | Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumab. | J Immunol | 2011 | https://conductscience.org/library/papers/21296976 | PubMed |
| 3 | 27161864 | Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood. | J Proteome Res | 2016 | https://conductscience.org/library/papers/27161864 | PubMed |
| 4 | 29592963 | Single Degranulations in NK Cells Can Mediate Target Cell Killing. | J Immunol | 2018 | https://conductscience.org/library/papers/29592963 | PubMed |
| 5 | 28163018 | Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. | J Immunol Methods | 2017 | https://conductscience.org/library/papers/28163018 | PubMed |
| 6 | 23487023 | NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). | Blood | 2013 | https://conductscience.org/library/papers/23487023 | PubMed |
| 7 | 20536565 | Once a killer, always a killer: from cytotoxic T cell to memory cell. | Immunol Rev | 2010 | https://conductscience.org/library/papers/20536565 | PubMed |
| 8 | 36513064 | Antibody effector functions are associated with protection from respiratory syncytial virus. | Cell | 2022 | https://conductscience.org/library/papers/36513064 | PubMed |
| 9 | 24704820 | Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells. | J Immunol Methods | 2014 | https://conductscience.org/library/papers/24704820 | PubMed |
| 10 | 6265471 | Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains. | J Cell Biol | 1981 | https://conductscience.org/library/papers/6265471 | PubMed |
| 11 | 1939168 | Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1939168 | PubMed |
| 12 | 23319732 | Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. | J Immunol | 2013 | https://conductscience.org/library/papers/23319732 | PubMed |
| 13 | 12144129 | CD107a (LAMP-1) and CD107b (LAMP-2). | J Biol Regul Homeost Agents | 2002 | https://conductscience.org/library/papers/12144129 | PubMed |
| 14 | 2022921 | Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. | J Exp Med | 1991 | https://conductscience.org/library/papers/2022921 | PubMed |
| 15 | 2032551 | Effects of Brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells. | Eur J Cell Biol | 1991 | https://conductscience.org/library/papers/2032551 | PubMed |
| 16 | 29903548 | Antibody glycosylation in inflammation, disease and vaccination. | Semin Immunol | 2018 | https://conductscience.org/library/papers/29903548 | PubMed |
| 17 | 23851282 | Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions. | Methods | 2014 | https://conductscience.org/library/papers/23851282 | PubMed |
| 18 | 23006327 | Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. | J Clin Invest | 2012 | https://conductscience.org/library/papers/23006327 | PubMed |
| 19 | 30016589 | Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan. | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/30016589 | PubMed |
| 20 | 34349345 | An NK cell line (NK92-41BB) expressing high levels of granzyme is engineered to express the high affinity chimeric genes CD16/CAR. | Cytotechnology | 2021 | https://conductscience.org/library/papers/34349345 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41961075 | Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/41961075 | PubMed |
| 40177643 | Fc gamma receptor polymorphisms in antibody therapy: implications for bioassay development to enhance product quality. | Antib Ther | 2025 | https://conductscience.org/library/papers/40177643 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37489366
GET https://conductscience.org/api/papers/v1/37489366/references?page=2